You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular Alterations

Showing 1 - 25 of 7,680
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

Recruiting
  • Malignant Solid Neoplasms
  • Nilotinib (400 mg BID)
  • +6 more
  • Bordeaux, France
  • +6 more
Dec 15, 2022

Metastatic Breast Cancer Trial in France (Biopsy)

Completed
  • Metastatic Breast Cancer
  • Biopsy
  • Angers, France
  • +11 more
Sep 19, 2022

Cerebral Aneurysm Trial in Miami (Microsurgical clipping, Endovascular treatment, Sirolimus)

Recruiting
  • Cerebral Aneurysm
  • Microsurgical clipping
  • +2 more
  • Miami, Florida
    University of Miami
Oct 28, 2021

Solid Tumor, Hematological Malignancy Trial in Bayonne, Bordeaux, Pau (Newly obtained biopsy and Blood samples collection)

Recruiting
  • Solid Tumor
  • Hematological Malignancy
  • Newly obtained biopsy and Blood samples collection
  • Bayonne, France
  • +5 more
Feb 1, 2022

Molecular Profiling in Prostate Cancer

Recruiting
  • Prostate Cancer Metastatic
  • +4 more
  • Tumor molecular profiling
  • Athens, Greece
    Hellenic Cooperative Oncology Group
Mar 15, 2022

Ovarian Cancer, Triple-Negative Breast Cancer, Head Neck Cancer Trial in Paris, Saint-cloud (Tumor biopsies / Tumor surgery,

Recruiting
  • Ovarian Cancer
  • +2 more
  • Tumor biopsies / Tumor surgery
  • Blood withdrawal
  • Paris, France
  • +1 more
Dec 13, 2021

Cancer, Solid Tumor, Adult Trial in France (research of druggable molecular alterations on tumor biopsy)

Active, not recruiting
  • Cancer
  • Solid Tumor, Adult
  • research of druggable molecular alterations on tumor biopsy
  • Bordeaux, France
  • +3 more
May 16, 2022

SLPI for Prostate Cancer

Recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • Secretory leukocyte protease inhibitor (SLPI) in prostate cancer
  • +2 more
  • Florence, Tuscany, Italy
    Careggi University Hospital
May 6, 2022

Tumor Metastasis Trial in Marseille (biopsy or surgical sampling, blood sampling)

Active, not recruiting
  • Neoplasm Metastasis
  • biopsy or surgical sampling
  • blood sampling
  • Marseille, France
    Institut Paoli-Calmettes
Jan 21, 2021

Glioblastoma Trial in Zhengzhou (Individualized intervention based on genomic alterations)

Enrolling by invitation
  • Glioblastoma
  • Individualized intervention based on genomic alterations
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Sep 10, 2022

Lung Cancer, Stage III Lung Cancer, Unresectable Lung Carcinoma Trial in Barcelona (procedure, diagnostic test, drug)

Recruiting
  • Lung Cancer
  • +2 more
  • Sample collection
  • +3 more
  • Barcelona, Spain
    Parc de Salut Mar - Hospital del Mar
Dec 8, 2022

Female Athlete Triad, Energy Deficit Syndrome, Mediterranean Diet Trial in Elche (Free use of the virtual platform.,

Recruiting
  • Female Athlete Triad
  • +6 more
  • Free use of the virtual platform.
  • +2 more
  • Elche, Alicante, Spain
    Alejandro Martínez Rodriguez
Oct 5, 2022

Advanced Solid Tumours Trial in France, Spain, United States (Ceralasertib)

Recruiting
  • Advanced Solid Tumours
  • Tucson, Arizona
  • +31 more
Jan 13, 2023

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)

Completed
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Orange, California
  • +9 more
Jun 7, 2021

Resistance to Oral Therapy in Lung Cancer

Completed
  • Non Small Cell Lung Cancer
  • Description of the molecular alterations detected in blood samples of patients treated by osimertinib
  • Montpellier, Hérault, France
    University Hospital
Dec 28, 2020

Genetic Alterations in Pediatric Solid Tumors

Recruiting
  • Pediatric Solid Tumors
    • Ciudad Autónoma de Buenos Aires, Argentina
      Maria Victoria Preciado
    Feb 25, 2021

    ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC Trial in Worldwide (PF-06463922, Crizotinib)

    Active, not recruiting
    Has Results
    • ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
    • Fayetteville, Arkansas
    • +71 more
    Feb 16, 2022

    Glioma Trial (Blood sampling)

    Not yet recruiting
    • Glioma
    • Blood sampling
    • (no location specified)
    Oct 31, 2023

    Rare Malignant Tumor Trial (Imatinib)

    Not yet recruiting
    • Rare Malignant Neoplasm
    • (no location specified)
    Nov 1, 2023

    Brain Metastases Trial (biological samples (blood test and lumbar puncture))

    Not yet recruiting
    • Brain Metastases
    • biological samples (blood test and lumbar puncture)
    • (no location specified)
    May 4, 2023

    Cancer Trial in Berlin

    Recruiting
    • Cancer
      • Berlin, Germany
        Charité Comprehensive Cancer Center
      Jun 21, 2023

      Cancer Trial in Milwaukee (Targeted agent, Standard of care agent)

      Not yet recruiting
      • Cancer
      • Targeted agent
      • Standard of care agent
      • Milwaukee, Wisconsin
        Froedtert Hospital & the Medical College of Wisconsin
      Jan 8, 2023

      Lung Cancer Trial in Brampton (Questionnaires)

      Recruiting
      • Lung Cancer
      • Questionnaires
      • Brampton, Ontario, Canada
        Milena (Lynn) Vicente
      Jun 17, 2022

      Solid Tumors, Hematologic Cancers, Metastatic Cancers Trial in Paris (Vemurafenib)

      Active, not recruiting
      • Solid Tumors
      • +2 more
      • Paris, France
        Tredaniel
      May 18, 2022

      Tumor Molecular Profiling in Patients With Prostate Cancer

      Completed
      • Prostate Cancer
      • Metastatic Prostate Adenocarcinoma
      • Tumor molecular profiling
      • Athens, Greece
        Hellenic Cooperative Oncology Group
      Oct 17, 2022